Gallardo, Riley Xavier .

HRN: 20-85-06  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/17/2022
06/23/2022
IVT
245mg
Q6
PCAP C
Waiting Final Action 
06/17/2022
AMPICILLIN 500MG (VIAL)
06/17/2022
06/24/2022
IV
500 Mg
Q6H
PCAP-C Benign Febrile Convulsion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: